Covid Vax is a biotechnology firm that is about to announce the results of its clinical trials of a potential new vaccine. If the trials are successful Covid Vax stock will be worth 85.6 per share. However, if the trials are not successful, then CovidVax stock will only be worth 19.8 per share If on the morning that the announcement is scheduled, Covid var stock is trading at 765, then compute the implied probability that investors must be placing on the triats being successful